Comparing Treatments for Diabetic Retinopathy: PRP vs. IVB
Author Information
Author(s): Khojasteh Hassan, Ahadi Fard Moghadam Mohammad, Rahimi Masoud, Mirzaei Arash, Ghassemi Fariba, Takzare Alireza, Faghihi Hooshang, Khalili Pour Elias, Riazi-Esfahani Hamid
Primary Institution: Tehran University of Medical Sciences
Hypothesis
How do panretinal photocoagulation (PRP) and intravitreal bevacizumab (IVB) affect optic disc microcirculation in diabetic retinopathy patients?
Conclusion
PRP significantly reduced vascular density in the optic disc and peripapillary regions, while IVB resulted in a slight increase in vascular density but a significant reduction in RNFL thickness.
Supporting Evidence
- PRP treatment significantly reduced vascular density in the optic disc and peripapillary region over 3 months.
- IVB treatment led to a slight increase in optic disc vascular density while significantly reducing RNFL thickness.
- No significant correlation was found between changes in RNFL thickness and peripapillary vascular density.
Takeaway
Doctors compared two treatments for eye problems caused by diabetes. One treatment made blood vessels in the eye smaller, while the other treatment had a different effect.
Methodology
This was a retrospective comparative case series involving 50 eyes of 29 diabetic patients, with measurements taken at baseline, 1 month, and 3 months after treatment.
Potential Biases
The retrospective design may introduce inherent biases.
Limitations
The study had a small sample size and a limited follow-up period, which may affect the generalizability of the results.
Participant Demographics
The mean age of participants was 62.1 years, with 48.2% male and 51.7% female.
Statistical Information
P-Value
p=0.001
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website